YouTube video by UMMCVideos

How I stabilized my symptoms before trying immune stimulants

How I targeted the SARS-CoV-2 virus, and got rid of my post-exertional malaise.

During the COVID-19 pandemic it was widely described that certain individuals infected by SARS-CoV-2 experience persistent disease signs and symptoms, Long COVID, which in some cases is very severe wi...

Slower viral RNA clearance rates during acute coronavirus disease 2019 (COVID-19) were associated with an increased risk of long COVID and more long COVID

Women experiencing conditions such as heavy periods and endometriosis are being dismissed when they ask for help, a report warns.

With no approved treatments, lack of support, and stigma against the disease, many people with Long COVID are using overseas pharmacies to source medications. Some of these treatments are widely used ...

FDA Approval for Monoclonal Antibody Treatment BREAKING NEWS! PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH! Watch/listen to this week’s podcast interview where Professor Nancy Kl...

Phase 3 trials conducted in the NIAID COVID-19 Prevention Network.

A disease that's prevalent in women highlights the female sex bias in medicine

Like all viruses, SARS-CoV-2, the causative agent of COVID-19, relies on host cell resources to replicate. Our study reveals that, among these resources, SARS-CoV-2 hijacks the oxysterol-binding prote...

Around 5–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.